Loading...
PhD Simon Žakelj

PhD Simon Žakelj
no.: 22659 source: ARIS

researcher – active in research organisation
Phone number 01 47 69 500
  simon.zakeljat signffa.uni-lj.si
Foreign language skills
Research activity

Code Science Field Subfield
1.09.00  Natural sciences and mathematics  Pharmacy   
Keywords
Permeability, absortption through rat jejunum, Sweetana-Grass diffusion cells, artificial membranes
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Points
310.12
A''
15.18
A'
186.96
A1/2
186.96
CI10
983
CImax
130
h10
16
A1
1.08
A3
0.92
Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024 (2019, 2020, 2021, 2023)
Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 44  1,132  991  22.52 
Scopus 44  1,232  1,083  24.61 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
  B. Sc.   Pharmacy  SI University of Ljubljana, Faculty of Pharmacy 2001 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Pharmacy 2006 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (120%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair of Pharmaceutical Technology  1/1/2002  Assistant  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J1-50023  3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation   10/1/2023 - 9/30/2026  PhD Andrej Emanuel Cotman   1,199 
2. J1-50037  Development of CDK1-selective degraders for the treatment of T-cell malignancies   10/1/2023 - 9/30/2026  PhD Izidor Sosič   1,278 
3. J4-50139  Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system   10/1/2023 - 9/30/2026  PhD Alen Albreht   1,477 
4. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   10/1/2022 - 9/30/2026  PhD Lucija Peterlin Mašič   6,640 
5. L1-3160  Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration   10/1/2021 - 9/30/2024  PhD Iztok Grabnar   3,178 
6. J1-2484  Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis   9/1/2020 - 8/31/2023  PhD Stanislav Gobec   4,164 
7. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   3/1/2016 - 2/28/2019  PhD Igor Emri   4,681 
8. J3-4313  Vpliv aktivnega transporta imatiniba in različnih genotipov pacientov na uspešnost terapije kronične mieloične levkemije (Slovene)   7/1/2011 - 6/30/2014  PhD Albin Kristl   3,298 
9. J1-0957  Pharmacogenetic study of raloxifene metabolism and transport   2/1/2008 - 1/30/2011  PhD Aleš Mrhar   2,034 
ARIS research and infrastructure programmes Legend
source: ARIS
Views history
Favourite